Tan T Q, Mason E O, Barson W J, Wald E R, Schutze G E, Bradley J S, Arditi M, Givner L B, Yogev R, Kim K S, Kaplan S L
Pediatric Infectious Disease, Chicago, Illinois, USA.
Pediatrics. 1998 Dec;102(6):1369-75. doi: 10.1542/peds.102.6.1369.
To compare the clinical characteristics, treatment, and outcome of pediatric patients with pneumonia attributable to isolates of Streptococcus pneumoniae that were either susceptible or nonsusceptible to penicillin.
Multicenter, retrospective study.
Eight children's hospitals in the United States.
Two hundred fifty-four children with pneumococcal pneumonia identified from patients enrolled in the United States Pediatric Multicenter Pneumococcal Surveillance Study during the 3-year period from September 1, 1993 to August 31, 1996.
Demographic and clinical variables including necessity for and duration of hospitalization, frequency of chest tube placement, antimicrobial therapy, susceptibility of isolates, and clinical outcome.
There were 257 episodes of pneumococcal pneumonia that occurred in 254 patients. Of the 257 isolates, 22 (9%) were intermediate and 14 (6%) were resistant to penicillin; 7 (3%) were intermediate to ceftriaxone and 5 (2%) were resistant to ceftriaxone. There were no differences noted in the clinical presentation of the patients with susceptible versus nonsusceptible isolates. Twenty-nine percent of the patients had a pleural effusion. The 189 (74%) hospitalized patients were more likely to have an underlying illness, multiple lung lobe involvement, and the presence of a pleural effusion than nonhospitalized patients. Fifty-two of 72 hospitalized patients with pleural effusions had a chest tube placed, and 27 subsequently underwent a decortication drainage procedure. Eighty percent of the patients treated as outpatients and 48% of the inpatients received a parenteral second or third generation cephalosporin followed by a course of an oral antimicrobial agent. Two hundred forty-eight of the patients (97.6%) had a good response to therapy. Six patients died; however, only 1 of the deaths was related to the pneumococcal infection.
The clinical presentation and outcome of therapy did not differ significantly between patients with penicillin-susceptible versus those with nonsusceptible isolates of S pneumoniae. Hospitalized patients were more likely to have underlying illnesses, multiple lobe involvement, and the presence of pleural effusions than patients who did not require hospitalization. In otherwise normal patients with pneumonia attributable to penicillin-resistant pneumococcal isolates, therapy with standard beta-lactam agents is effective.
比较对青霉素敏感或不敏感的肺炎链球菌分离株所致小儿肺炎患者的临床特征、治疗及转归。
多中心回顾性研究。
美国八家儿童医院。
1993年9月1日至1996年8月31日这3年期间,从参与美国儿科多中心肺炎链球菌监测研究的患者中确诊的254例肺炎链球菌肺炎患儿。
人口统计学和临床变量,包括住院必要性和住院时间、胸管置入频率、抗菌治疗、分离株的敏感性及临床转归。
254例患者共发生257次肺炎链球菌肺炎发作。在257株分离株中,22株(9%)对青霉素中介,14株(6%)对青霉素耐药;7株(3%)对头孢曲松中介,5株(2%)对头孢曲松耐药。青霉素敏感与不敏感分离株的患者临床表现无差异。29%的患者有胸腔积液。189例(74%)住院患者比未住院患者更易有基础疾病、多肺叶受累及胸腔积液。72例有胸腔积液的住院患者中,52例行胸管置入,27例随后接受了胸膜剥脱引流术。80%的门诊治疗患者和48%的住院患者接受了胃肠外第二代或第三代头孢菌素治疗,随后口服抗菌药物一个疗程。248例患者(97.6%)治疗反应良好。6例患者死亡;然而,仅1例死亡与肺炎链球菌感染有关。
青霉素敏感与不敏感肺炎链球菌分离株的患者,其临床表现和治疗转归无显著差异。住院患者比无需住院的患者更易有基础疾病、多叶受累及胸腔积液。在其他方面正常的、由耐青霉素肺炎链球菌分离株所致肺炎患者中,使用标准β-内酰胺类药物治疗有效。